Zions Bancorporation’s iShares US Medical Devices ETF IHI Stock Holding History

Zions Bancorporation’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-317	Closed	-$16K	–	998
2022 Q2	$16K	Sell	317 -57	-15%	-$3.11K	﹤0.01%	643
2022 Q1	$23K	Buy	+374	New	+$22.3K	﹤0.01%	653

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Zions Bancorporation's IHI Position: Q3 2022 in Review

Zions Bancorporation sold out of iShares US Medical Devices ETF (IHI) in Q3 2022, closing a stake of 317 shares — an estimated $16K sold.

Zions Bancorporation first reported a position in IHI in Q1 2022 and held it in 2 quarters. The position peaked at $23K in Q1 2022. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

Zions Bancorporation reported no remaining iShares US Medical Devices ETF position as of Q3 2022 after selling out during the quarter.
Zions Bancorporation sold 317 iShares US Medical Devices ETF shares in Q3 2022, an estimated $16K.
Zions Bancorporation first reported a position in iShares US Medical Devices ETF in Q1 2022 and held it in 2 quarters.
Zions Bancorporation's iShares US Medical Devices ETF position peaked at $23K in Q1 2022.
556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on Zions Bancorporation's 13F filing for Q3 2022, filed 8 Nov 2022.